Vincerx Pharma EBITDA vs. Current Ratio
| VINC Stock | USD 0.26 0.01 4.00% |
EBITDA | First Reported 2010-12-31 | Previous Quarter -42.6 M | Current Value -44.7 M | Quarterly Volatility 25.4 M |
For Vincerx Pharma profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Vincerx Pharma to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Vincerx Pharma utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Vincerx Pharma's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Vincerx Pharma over time as well as its relative position and ranking within its peers.
Vincerx |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vincerx Pharma. If investors know Vincerx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vincerx Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.14) | Return On Assets (0.66) | Return On Equity (1.42) |
The market value of Vincerx Pharma is measured differently than its book value, which is the value of Vincerx that is recorded on the company's balance sheet. Investors also form their own opinion of Vincerx Pharma's value that differs from its market value or its book value, called intrinsic value, which is Vincerx Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vincerx Pharma's market value can be influenced by many factors that don't directly affect Vincerx Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vincerx Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vincerx Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vincerx Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Vincerx Pharma Current Ratio vs. EBITDA Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Vincerx Pharma's current stock value. Our valuation model uses many indicators to compare Vincerx Pharma value to that of its competitors to determine the firm's financial worth. Vincerx Pharma is rated below average in ebitda category among its peers. It is rated below average in current ratio category among its peers . At present, Vincerx Pharma's EBITDA is projected to decrease significantly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Vincerx Pharma's earnings, one of the primary drivers of an investment's value.Vincerx Current Ratio vs. EBITDA
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Vincerx Pharma |
| = | (42.61 M) |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company.
Vincerx Pharma |
| = | 7.88 X |
Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).
Vincerx Current Ratio Comparison
Vincerx Pharma is currently under evaluation in current ratio category among its peers.
Vincerx Pharma Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Vincerx Pharma, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Vincerx Pharma will eventually generate negative long term returns. The profitability progress is the general direction of Vincerx Pharma's change in net profit over the period of time. It can combine multiple indicators of Vincerx Pharma, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 8 K | 8.4 K | |
| Operating Income | -42.6 M | -44.7 M | |
| Income Before Tax | -40.2 M | -42.2 M | |
| Net Loss | -58.8 M | -55.9 M | |
| Net Loss | -40.2 M | -42.2 M | |
| Income Tax Expense | -7.4 M | -7.8 M | |
| Net Interest Income | 1.5 M | 1.6 M | |
| Net Loss | -48.9 M | -51.3 M | |
| Non Operating Income Net Other | -5.3 M | -5.6 M | |
| Total Other Income Expense Net | 2.5 M | 2.3 M | |
| Interest Income | 1.5 M | 798.2 K | |
| Change To Netincome | -40.5 K | -38.5 K | |
| Net Loss | (1.89) | (1.98) | |
| Income Quality | 1.01 | 0.58 | |
| Net Income Per E B T | 1.01 | 0.84 |
Vincerx Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Vincerx Pharma. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Vincerx Pharma position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Vincerx Pharma's important profitability drivers and their relationship over time.
Use Vincerx Pharma in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vincerx Pharma position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vincerx Pharma will appreciate offsetting losses from the drop in the long position's value.Vincerx Pharma Pair Trading
Vincerx Pharma Pair Trading Analysis
The ability to find closely correlated positions to Vincerx Pharma could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vincerx Pharma when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vincerx Pharma - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vincerx Pharma to buy it.
The correlation of Vincerx Pharma is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vincerx Pharma moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vincerx Pharma moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vincerx Pharma can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Vincerx Pharma position
In addition to having Vincerx Pharma in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Drugs Thematic Idea Now
Drugs
Companies involved in medical and pharmaceutical drug research, manufacturing, and delivery. The Drugs theme has 38 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Drugs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map. For information on how to trade Vincerx Stock refer to our How to Trade Vincerx Stock guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
To fully project Vincerx Pharma's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Vincerx Pharma at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Vincerx Pharma's income statement, its balance sheet, and the statement of cash flows.